Company / Interest Expense per Share
SUTRO BIOPHARMA, INC. Interest Expense per Share History
FY2018-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.05
FY2023
5-year range
$0.02 / $0.05
FY2019-FY2023
Trend
-8.9%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense per Share has fluctuated over the past 6 years, ranging from $0.00 in FY2018 to $0.07 in FY2020.
Based on SEC 10-K filings.
0.05 in FY2023 with a 3-year CAGR of -13.3%.
Increased from $0.02 to $0.05 over the past 2 years.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -13.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, interest expense per share decreased 8.9% year-over-year.
- Peak interest expense per share was recorded in FY2020.
- Lowest interest expense per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -3.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.05 | -8.9% |
| FY2022 | $0.05 | +106.5% |
| FY2021 | $0.02 | -65.3% |
| FY2020 | $0.07 | +163.8% |
| FY2019 | $0.03 | - |
| FY2018 | $0.00 | - |
As of FY2023 · SEC 10-K · Updated Jun 28, 2026